Frey N - Search Results

1

Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI).

Lutz M, von Ingersleben N, Lambers M, Rosenberg M, Freitag-Wolf S, Dempfle A, Lutter G, Frank J, Bramlage P, Frey N, Frank D. Lutz M, et al. Among authors: frey n. Open Heart. 2017 Jun 10;4(2):e000633. doi: 10.1136/openhrt-2017-000633. eCollection 2017. Open Heart. 2017. PMID: 28761684 Free PMC article.

2

The sarcomeric Z-disc: a nodal point in signalling and disease.

Frank D, Kuhn C, Katus HA, Frey N. Frank D, et al. Among authors: frey n. J Mol Med (Berl). 2006 Jun;84(6):446-68. doi: 10.1007/s00109-005-0033-1. Epub 2006 Jan 17. J Mol Med (Berl). 2006. PMID: 16416311 Review.

3

Rapid progressive eosinophilic cardiomyopathy in a patient with Churg-Strauss syndrome (CSS).

Rosenberg M, Lorenz HM, Gassler N, Katus HA, Frey N. Rosenberg M, et al. Among authors: frey n. Clin Res Cardiol. 2006 May;95(5):289-94. doi: 10.1007/s00392-006-0364-0. Epub 2006 Feb 27. Clin Res Cardiol. 2006. PMID: 16598400

4

Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells.

Lutz M, Rosenberg M, Kiessling F, Eckstein V, Heger T, Krebs J, Ho AD, Katus HA, Frey N. Lutz M, et al. Among authors: frey n. Cardiovasc Res. 2008 Jan;77(1):143-50. doi: 10.1093/cvr/cvm027. Epub 2007 Sep 27. Cardiovasc Res. 2008. PMID: 18006465

5

Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.

Frank D, Kuhn C, van Eickels M, Gehring D, Hanselmann C, Lippl S, Will R, Katus HA, Frey N. Frank D, et al. Among authors: frey n. Circulation. 2007 Nov 27;116(22):2587-96. doi: 10.1161/CIRCULATIONAHA.107.711317. Epub 2007 Nov 19. Circulation. 2007. PMID: 18025526

6

Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program.

Frank D, Kuhn C, Brors B, Hanselmann C, Lüdde M, Katus HA, Frey N. Frank D, et al. Among authors: frey n. Hypertension. 2008 Feb;51(2):309-18. doi: 10.1161/HYPERTENSIONAHA.107.098046. Epub 2007 Dec 24. Hypertension. 2008. PMID: 18158353

7

DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.

Kuhn C, Frank D, Will R, Jaschinski C, Frauen R, Katus HA, Frey N. Kuhn C, et al. Among authors: frey n. J Biol Chem. 2009 Jun 19;284(25):17320-17327. doi: 10.1074/jbc.M109.006759. Epub 2009 Apr 16. J Biol Chem. 2009. PMID: 19372220 Free PMC article.

8

FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.

Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N. Chorianopoulos E, et al. Among authors: frey n. Basic Res Cardiol. 2010 Mar;105(2):301-13. doi: 10.1007/s00395-009-0046-y. Epub 2009 Jul 23. Basic Res Cardiol. 2010. PMID: 19629561

9

Role of the sarcomeric Z-disc in the pathogenesis of cardiomyopathy.

Frank D, Kuhn C, Katus HA, Frey N. Frank D, et al. Among authors: frey n. Future Cardiol. 2007 Nov;3(6):611-22. doi: 10.2217/14796678.3.6.611. Future Cardiol. 2007. PMID: 19804282

10

Osteopontin, a new prognostic biomarker in patients with chronic heart failure.

Rosenberg M, Zugck C, Nelles M, Juenger C, Frank D, Remppis A, Giannitsis E, Katus HA, Frey N. Rosenberg M, et al. Among authors: frey n. Circ Heart Fail. 2008 May;1(1):43-9. doi: 10.1161/CIRCHEARTFAILURE.107.746172. Circ Heart Fail. 2008. PMID: 19808269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

827 results

Search Page

Filters